Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine

Research in Virology

Volumn 148, Issue 2, 1997, Pages 109-114

  Da Villa, G ^a   Pelliccia, M G ^b   Peluso, F ^b   Ricciardi, E ^a   Sepe, A ^a  

^a Ital Inst for Prev of Liver D   (Italy)

^b ASL Napoli 3 Sud   (Italy)

Author keywords

anti HBc markers; anti HBs markers; DNA recombinant vaccine; hepatitis B; plasma derived vaccine; vaccination

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ANTIBODY RESPONSE; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINATION;

HEPATITIS B VIRUS;

EID: 0030947932     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(97)89893-7     Document Type: Conference Paper

References (10)

1. Cassidy, W., Watson, B. & Williams, K. (1996), Immune response of healthy adolescents to 2 and 3 dose regimens of a recombinant hepatitis B vaccine, Abstract volume of the IX Triennal International Symposium on Viral Hepatitis, Rome, April 21-25 1996.
2. Coursaget, P., Yvonnet, B., Chotard, J., Sarr, M., Vincelot, F. & N'Doye, R. (1986), Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet, 1143-1145.
3. Fortuin, M., Chotard, J., Jack, A.D., Maine, N.F., Mendy, M., Hall, A.J. et al. (1993), Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunization. Lancet, 341, 1129-1131.
4. Hall, J.A. (1993), Hepatitis B vaccination: protection for how long and against what? Br. Med. J., 307, 276-277.
5. Kane, M. (1995), Global programme for control of hepatitis B infection. Vaccine, 13, S1, 547-549.
6. Margolis, H.S., Coleman, P.J., Brown, R.E., Mast, E.E., Sheingold, S.H. & Arevalo, J.A. (1995), Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. Jama, 274, 1201-1208.
7. Piazza, M., Picciotto, L., Villari, R. et al. (1985a), Hepatitis B immunization with a reduced number of doses in newborn babies and children. Lancet, I, 949-951.
8. Piazza, M., Picciotto, L., Villari, R. et al. (1985b), Two-dose hepatitis B immunization regimen for infants. Lancet, II, 1120-1121.
9. Wainwright, R.B., McMahon, B.J., Bulkow, L.R., Hall, D.B., Fitzgerald, M.A., Harpster, A.P. et al (1989), Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA, 261, 2562-2566.
10. Whittle, H.C., Inskip, H., Hall, A.J., Mendy, M., Downes, R. & Hoare, S. (1991), Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet, 337, 747-750.